glp-1 nausea law office in louisiana lawmakers are considering a bill that would expand Medicaid access to drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Louisiana state insurance plans spend

Inside, we cover the heavy hitters everyone's watching: Semaglutide, Tirzepatide, and the one to keep your eye on next, Orforglipron (Foundayo)

rates: 3.71 versus 3.56

Gastrointestinal side effects are a little more common in the oral version than in the injectables

Cardiologists also had a greater tendency than the other specialties to give the International Non-proprietary Name (INN) of new GLP-1s, rather than the brand name.

Researchers are working to understand the effects of these popular new therapies on ocular structures.

This was a retrospective cohort study of adult patients with a body mass index (BMI)30kg/m2 prescribed GLP-1 analogue therapy at an obesity specialist clinic in Vancouver, Canada